Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1 Methyl 4 (4 aminophenyl)piperazine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101168532B reveals a cost-effective two-step synthesis for N-methylpiperazine substituted aniline, offering significant supply chain advantages for pharmaceutical manufacturing.